Change in Dyslipidemia with Declining Glomerular Filtration Rate and Increasing Proteinuria in Children with CKD

Jeffrey M Saland1, Juan C Kupferman2, Christopher B Pierce3

  • 1Division of Pediatric Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.

Insights

Dyslipidemia is common in children with chronic kidney disease (CKD) and worsens with declining kidney function, increased proteinuria, and higher body mass index (BMI). These lipid changes are linked to CKD progression, impacting cardiovascular risk.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Risk Factors
  • Lipid Metabolism

Background:

  • Dyslipidemia is a known cardiovascular disease risk factor, frequently observed in children with chronic kidney disease (CKD).
  • The longitudinal changes in dyslipidemia and its relationship with CKD progression in pediatric populations have not been well-described.

Purpose of the Study:

  • To prospectively investigate the temporal relationship between lipid changes and CKD progression in children.
  • To quantify how changes in glomerular filtration rate (GFR), proteinuria, and body mass index (BMI) influence lipid profiles over time in pediatric CKD.

Main Methods:

  • Prospective cohort study (CKD in Children) of 508 children with progressive CKD.
  • Utilized multivariable linear mixed-effects models to analyze longitudinal changes in lipids (HDL, non-HDL cholesterol, triglycerides) against GFR, proteinuria, and BMI.
  • Median follow-up of 4 years with 2-6 lipid measurements per child.

Main Results:

  • Dyslipidemia was prevalent at baseline (35-43%) and increased with age, particularly in children with glomerular CKD.
  • Increased proteinuria correlated with higher non-HDL cholesterol and triglycerides.
  • Declining GFR was associated with decreased HDL cholesterol (nonglomerular CKD) and increased non-HDL cholesterol (glomerular CKD).
  • Increased BMI showed significant associations with lipid changes, especially in glomerular CKD.

Conclusions:

  • Dyslipidemia is a persistent complication in pediatric CKD, worsening with disease progression.
  • Declining GFR, increasing proteinuria, and rising BMI are independently associated with adverse lipid changes in children with CKD.
  • These findings highlight the need for monitoring and managing dyslipidemia in pediatric CKD to mitigate cardiovascular risk.
Abstract

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
445
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
497
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
523
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
304
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
147
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
167